Organisation
Clinical and Diagnostic Immunology
Lab
This laboratory studies the regulation of the immune response to Streptococcus pneumoniae, immunodeficiencies (with particular interest on innate immunity), and autoimmunity (with particular interest on serological markers).
Current researchers
1 - 8 of 8 results
- Xavier Bossuyt (Responsible)
- Xavier Bossuyt (Member)
- Jonas De Leeuw (Member)
- Lisa Dewitte (Member)
- Glynis Frans (Member)
- Louis Nevejan (Member)
- Lieve Van Hoovels (Member)
- Jean-Baptiste Vulsteke (Member)
Projects
1 - 10 of 36
- Ultra-sensitive minimal residual disease assessment by blood-based clonotypic mass spectrometry approach in plasma cell dyscrasias (MASSIAS)From1 Jan 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Characterization of allergen-specific T and B cells associated with tolerance induction in food allergic childrenFrom1 Nov 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- B-specific: B-cell related gene and protein markers with prognostic and therapeutic value for CVDFrom1 Oct 2023 → TodayFunding: Horizon Europe - European Innovation Council (EIC)
- Closing the seronegative gap in rheumatoid arthritis diagnosis using B-cell receptor sequencing combined with mass spectrometric analysis of complementarity determining regions.From1 Oct 2023 → TodayFunding: Other federal public and semi-governmental institutions
- Ultra-sensitive minimal residual disease assessment by blood-based clonotypic mass spectrometry approach in plasma cell dyscrasias (MASSIAS)From1 Oct 2023 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Mass spectrometry based immunoprofiling in rheumatoid arthritis patientsFrom1 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Targeted mass spectrometry-based quantification of autoantibodies in systemic rheumatic diseasesFrom1 Oct 2021 → 30 Sep 2023Funding: FWO Applied Biomedical Research (TBM)
- Why dose lung damage sometimes continue to worsen after the body seems to have cleared the SARS-CoV-2 virus?From1 Oct 2021 → 31 Mar 2023Funding: Foreign private sponsor - undefined
- Tumor necrosis factor Receptor-Associated Factors in signal transduction and susceptibility to infection.From9 Aug 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Tumor necrosis factor Receptor-Associated Factors in signal transduction and susceptibility to infection.From1 Jan 2021 → TodayFunding: FWO research project (including WEAVE projects)
Publications
21 - 30 of 433
- Frequency and Pattern of IgE-mediated Sensitization to Aero and Food Allergens in Ahvaz, Province of Khuzestan in Southwestern Iran(2018)
Authors: Mohammad Shahrooei, Johan Van Eldere, Xavier Bossuyt
Pages: 393 - 397 - Clinical relevance of ANCA in small-vessel vasculitis: positioning of antigen-specific immunoassays(2018)
Authors: Xavier Bossuyt
Pages: 2015 - 2016 - Variation in antinuclear antibody detection by automated indirect immunofluorescence analysis(2019)
Authors: Lieve Van Hoovels, Xavier Bossuyt
- Value-added reporting of specific IgE(2016)
Authors: Xavier Bossuyt, Jan Ceuppens
Pages: 1644 - There is no benefit in routinely monitoring ANCA titres in patients with granulomatosis with polyangiitis(2015)
Authors: Bram Verstockt, Xavier Bossuyt, Steven Vanderschueren, Daniel Engelbert Blockmans
Pages: 72 - 76 - Lung distribution, quantification, co-localization and speciation of silver nanoparticles after lung exposure in mice(2015)
Authors: Stijn Smulders, Jeroen Vanoirbeek, Peter Hoet
Pages: 1 - 6 - Integrating quality assurance in autoimmunity: the changing face of the automated ANA IIF test(2021)
Authors: Lieve Van Hoovels, Xavier Bossuyt
Pages: 1247 - 1255 - A multicentre study to improve clinical interpretation of proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibodies(2017)
Authors: Xavier Bossuyt, Pieter Vermeersch, Daniel Engelbert Blockmans
Pages: 1533 - 1541 - Nano-TiO2 modulates the dermal sensitization potency of dinitrochlorobenzene after topical exposure(2015)
Authors: Stijn Smulders, Erik Smolders, Jeroen Vanoirbeek, Peter Hoet
Pages: 392 - 9 - ANA as an entry criterion for the classification of SLE(2019)
Authors: Xavier Bossuyt